| NDC Code | 42494-409-01 |
|---|
| Package Description | 100 CAPSULE in 1 BOTTLE (42494-409-01) |
|---|
| Product NDC | 42494-409 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Chlordiazepoxide Hydrochloride And Clidinium Bromide |
|---|
| Non-Proprietary Name | Chlordiazepoxide Hydrochloride And Clidinium Bromide |
|---|
| Dosage Form | CAPSULE |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 19660901 |
|---|
| End Marketing Date | 20240630 |
|---|
| Marketing Category Name | NDA AUTHORIZED GENERIC |
|---|
| Application Number | NDA012750 |
|---|
| Manufacturer | Cameron Pharmaceuticals, LLC |
|---|
| Substance Name | CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE |
|---|
| Strength | 5; 2.5 |
|---|
| Strength Unit | mg/1; mg/1 |
|---|
| Pharmacy Classes | Anticholinergic [EPC], Benzodiazepine [EPC], Benzodiazepines [CS], Cholinergic Antagonists [MoA], Decreased Parasympathetic Acetylcholine Activity [PE], Digestive/GI System Activity Alteration [PE], GI Motility Alteration [PE] |
|---|
| DEA Schedule | CIV |
|---|